AYUSH
Clinically proven nano-curcumin with patented SNEDDS technology — 30x higher bioavailability. Bridging ancient Ayurvedic wisdom with modern pharmaceutical science.
The AYUSH Division of Arbro Group
Arbro's AYUSH vertical transforms Ayurveda into clinically proven, next-generation wellness solutions, led by SNEC30 — a patented nano-curcumin formulation using SNEDDS (Self-Nanoemulsifying Drug Delivery System) technology.
SNEC30 was co-created with DRDO and Jamia Hamdard University, supported by the Department of Science and Technology (DST), delivering 30x higher bioavailability than standard curcumin.
Under the leadership of Dr. Saurabh Arora, SNEC30 represents the pinnacle of evidence-based Ayurvedic innovation — bridging ancient wisdom with modern pharmaceutical science.
Focus Areas
Evidence-Based Formulation
Transforming traditional Ayurvedic wisdom into clinically proven, next-generation wellness solutions through patented nano-technology and rigorous scientific research.
Clinical & Scientific Validation
Every AYUSH product undergoes comprehensive clinical validation, ensuring efficacy claims are backed by robust scientific evidence and published research.
Global Wellness Acceptance
Formulated and validated to meet international quality standards, enabling global acceptance and market entry for Ayurvedic and herbal wellness products.
SNEDDS Technology
SNEC30's patented Self-Nanoemulsifying Drug Delivery System converts curcumin into nano-sized droplets, solving the age-old problem of curcumin's poor bioavailability.
SNEC30 Products
SNEC30 Nano-Curcumin Capsules
Patented nano-curcumin formulation using SNEDDS technology, delivering 30x higher bioavailability than standard curcumin supplements.
SNEC30 Plus
Advanced formulation combining nano-curcumin with synergistic ingredients for enhanced therapeutic benefits and targeted wellness support.
SNEC30 Professional 15mg
Entry-level professional-grade nano-curcumin capsules for daily wellness and preventive health support.
SNEC30 Professional 45mg
Mid-strength professional capsules for enhanced therapeutic benefits and chronic inflammation management.
SNEC30 Professional 60mg
High-potency nano-curcumin for clinical applications requiring stronger anti-inflammatory and antioxidant support.
SNEC30 Professional 120mg
Maximum strength nano-curcumin for intensive therapeutic use under clinical guidance.
Research & Development Partners
Defence Research and Development Organisation — co-creator of the SNEDDS nano-curcumin technology
Leading pharmaceutical research university — collaborative R&D partner for formulation development
Department of Science and Technology — research funding and support for nano-curcumin innovation
Frequently Asked Questions
What makes SNEC30 unique?
SNEC30 uses patented SNEDDS (Self-Nanoemulsifying Drug Delivery System) technology to deliver nano-curcumin with 30x higher bioavailability than standard curcumin, ensuring superior absorption and therapeutic effectiveness.
Is SNEC30 clinically validated?
Yes, SNEC30 was co-created with DRDO and Jamia Hamdard University, supported by the Department of Science and Technology (DST). It has undergone extensive clinical validation and scientific research.
What variants of SNEC30 are available?
SNEC30 is available in multiple variants: 15mg, 45mg, 60mg, and 120mg capsules, along with SNEC30 Plus and the Professional Range for clinical applications.
What is SNEDDS technology?
SNEDDS (Self-Nanoemulsifying Drug Delivery System) is a patented nano-technology that converts curcumin into nano-sized droplets, dramatically improving its absorption and bioavailability in the body.
Where can I purchase SNEC30 products?
SNEC30 products are available through our official website and authorized retailers. Visit snec30.com for complete product information and purchasing options.
Enquire About SNEC30
Interested in SNEC30 products for retail, clinical, or wholesale distribution? Get in touch with our team.
Experience the Future of Ayurvedic Wellness
Discover SNEC30 — patented nano-curcumin with 30x higher bioavailability, co-created with DRDO and backed by clinical science.
Visit SNEC30.com